National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

menatetrenone
A menaquinone compound and form of vitamin K2 with potential antineoplastic activity. Menatetrenone may act by modulating the signalling of certain tyrosine kinases, thereby affecting several transcription factors including c-myc and c-fos. This agent inhibits tumor cell growth by inducing apoptosis and cell cycle arrest. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Code name:E0167



Previous:Melan-A VLP vaccine, melanoma helper peptide vaccine, meloxicam, melphalan, memantine hydrochloride
Next:menogaril, Menogarol, meperidine hydrochloride, Meprolone, mercaptopurine

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov